- Investing Ideas
- Bangladeshi Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Bangladeshi Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
3
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
3 companies
Square Pharmaceuticals
Market Cap: ৳194.0b
Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳218.20
7D
-0.05%
1Y
-1.6%
Beximco Pharmaceuticals
Market Cap: ৳65.4b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally.
BXPHARMA
৳144.20
7D
-2.2%
1Y
8.7%
Renata
Market Cap: ৳53.5b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳465.20
7D
-1.3%
1Y
-2.8%